Silverback Therapeutics Stock Analysis
| SPRY Stock | 14.29 0.03 0.21% |
Silverback Therapeutics is undervalued with Real Value of 16.5 and Hype Value of 13.08. The main objective of Silverback Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Silverback Therapeutics is worth, separate from its market price. There are two main types of Silverback Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Silverback Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Silverback Therapeutics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Silverback Stock trading window is adjusted to America/New York timezone.
Silverback |
Silverback Stock Analysis Notes
About 23.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.5. Silverback Therapeutics had not issued any dividends in recent years. To find out more about Silverback Therapeutics contact the company at 858 771 9307 or learn more at https://ars-pharma.com.Silverback Therapeutics Investment Alerts
| Silverback Therapeutics generated a negative expected return over the last 90 days | |
| Silverback Therapeutics has high historical volatility and very poor performance | |
| Silverback Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 30 K. Net Loss for the year was (54.37 M) with loss before overhead, payroll, taxes, and interest of (14.71 M). | |
| Silverback Therapeutics generates negative cash flow from operations | |
| Silverback Therapeutics has a frail financial position based on the latest SEC disclosures | |
| About 68.0% of the company shares are owned by institutional investors |
Silverback Therapeutics Upcoming and Recent Events
Earnings reports are used by Silverback Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Silverback Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.39 B.Technical Drivers
As of the 1st of February, Silverback Therapeutics has the Variance of 15.09, coefficient of variation of (2,198), and Risk Adjusted Performance of (0.03). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Silverback Therapeutics, as well as the relationship between them.Silverback Therapeutics Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Silverback Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Silverback Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Silverback Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Silverback Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Silverback Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Silverback Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Silverback Therapeutics Outstanding Bonds
Silverback Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Silverback Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Silverback bonds can be classified according to their maturity, which is the date when Silverback Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Silverback Therapeutics Predictive Daily Indicators
Silverback Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Silverback Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Silverback Therapeutics Forecast Models
Silverback Therapeutics' time-series forecasting models are one of many Silverback Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Silverback Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Silverback Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Additional Tools for Silverback Stock Analysis
When running Silverback Therapeutics' price analysis, check to measure Silverback Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silverback Therapeutics is operating at the current time. Most of Silverback Therapeutics' value examination focuses on studying past and present price action to predict the probability of Silverback Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silverback Therapeutics' price. Additionally, you may evaluate how the addition of Silverback Therapeutics to your portfolios can decrease your overall portfolio volatility.